Phillipp Ivanyi

12PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 15, 2026
Real-World Data on the Use of Nivolumab Monotherapy in the Treatment of Advanced Renal Cell Carcinoma After Prior Therapy: Final Results from the Non-Interventional NORA Study.

|Nov 21, 2025
A Podcast Discussion on Medical Treatment in R/M-SCCHN in the Year 2025-Standard and Considerations for an Individualized Treatment.

Philipp Ivanyi, Tabea Fröhlich, Jonas Paul Wiegmann

|Jul 29, 2025
Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).

Johanna Falkenhorst, Philipp Ivanyi, Tom Schulz

|Dec 02, 2024
Regulatory T cells crosstalk with tumor cells and endothelium through lymphotoxin signaling.

Wenji Piao, Long Wu, Yanbao Xiong

|Apr 24, 2024
<i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz

|Jul 12, 2023
First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely.

Philipp Ivanyi, Jonas Paul Wiegmann, Hendrik Eggers

Pageof 2

Frequent Collaborators

3 joint publications

Viktor Grünwald

2 joint publications

Sebastian Bauer

2 joint publications

Bernd Kasper

1 joint publications

Gernot Beutel